217 related articles for article (PubMed ID: 16616907)
1. Metabolism of 1,3-butadiene to toxicologically relevant metabolites in single-exposed mice and rats.
Filser JG; Hutzler C; Meischner V; Veereshwarayya V; Csanády GA
Chem Biol Interact; 2007 Mar; 166(1-3):93-103. PubMed ID: 16616907
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
3. First-pass metabolism of 1,3-butadiene in once-through perfused livers of rats and mice.
Filser JG; Faller TH; Bhowmik S; Schuster A; Kessler W; Pütz C; Csanády GA
Chem Biol Interact; 2001 Jun; 135-136():249-65. PubMed ID: 11397395
[TBL] [Abstract][Full Text] [Related]
4. Quantitative investigation on the metabolism of 1,3-butadiene and of its oxidized metabolites in once-through perfused livers of mice and rats.
Filser JG; Bhowmik S; Faller TH; Hutzler C; Kessler W; Midpanon S; Pütz C; Schuster A; Semder B; Veereshwarayya V; Csanády GA
Toxicol Sci; 2010 Mar; 114(1):25-37. PubMed ID: 20007191
[TBL] [Abstract][Full Text] [Related]
5. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA
Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395
[TBL] [Abstract][Full Text] [Related]
6. Development of a physiologically based toxicokinetic model for butadiene and four major metabolites in humans: global sensitivity analysis for experimental design issues.
Brochot C; Smith TJ; Bois FY
Chem Biol Interact; 2007 May; 167(3):168-83. PubMed ID: 17397815
[TBL] [Abstract][Full Text] [Related]
7. 1,2:3,4-Diepoxybutane in blood of male B6C3F1 mice and male Sprague-Dawley rats exposed to 1,3-butadiene.
Csanády GA; Steinhoff R; Riester MB; Semder B; Pütz C; Li Q; Richter N; Kessler W; Klein D; Filser JG
Toxicol Lett; 2011 Dec; 207(3):286-90. PubMed ID: 21983653
[TBL] [Abstract][Full Text] [Related]
8. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
[TBL] [Abstract][Full Text] [Related]
9. Measurement of plasma or urinary metabolites and Hprt mutant frequencies following inhalation exposure of mice and rats to 3-butene-1,2-diol.
Walker DM; McDonald JD; Meng Q; Kracko DA; Bauer MJ; Seilkop SK; Walker EL; Henderson RF; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):191-206. PubMed ID: 17316587
[TBL] [Abstract][Full Text] [Related]
10. A novel DNA adduct, originating from 1,2-epoxy-3,4-butanediol, is the major DNA adduct after exposure to [2,3-(14)C]-1,3-butadiene,[4-(14)C]-1,2-epoxy-3-butane.
Boogaard PJ; van Sittert NJ; Watson WP; de Kloe KP
Chem Biol Interact; 2001 Jun; 135-136():687-93. PubMed ID: 11397423
[TBL] [Abstract][Full Text] [Related]
11. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
[TBL] [Abstract][Full Text] [Related]
12. DNA damage induced by three major metabolites of 1,3-butadiene in human hepatocyte L02 cells.
Zhang PP; Wen Y; An J; Yu YX; Wu MH; Zhang XY
Mutat Res; 2012 Sep; 747(2):240-5. PubMed ID: 22698567
[TBL] [Abstract][Full Text] [Related]
13. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides.
Boysen G; Georgieva NI; Upton PB; Walker VE; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):84-92. PubMed ID: 17084829
[TBL] [Abstract][Full Text] [Related]
14. Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol.
Powley MW; Li Y; Upton PB; Walker VE; Swenberg JA
Carcinogenesis; 2005 Sep; 26(9):1573-80. PubMed ID: 15888494
[TBL] [Abstract][Full Text] [Related]
15. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
Bond JA; Medinsky MA
Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
[TBL] [Abstract][Full Text] [Related]
16. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
Pianalto KM; Hartman JH; Boysen G; Miller GP
Toxicol Lett; 2013 Nov; 223(2):221-7. PubMed ID: 24021170
[TBL] [Abstract][Full Text] [Related]
17. The importance of 3,4-epoxy-1,2-butanediol and hydroxymethylvinyl ketone in 3-butene-1,2-diol associated mutagenicity.
Powley MW; Walker VE; Li Y; Upton PB; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):182-90. PubMed ID: 17349618
[TBL] [Abstract][Full Text] [Related]
18. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
19. 1,3-Butadiene: II. Genotoxicity profile.
Albertini RJ; Carson ML; Kirman CR; Gargas ML
Crit Rev Toxicol; 2010 Oct; 40 Suppl 1():12-73. PubMed ID: 20868267
[TBL] [Abstract][Full Text] [Related]
20. Butadiene diolepoxide- and diepoxybutane-derived DNA adducts at N7-guanine: a high occurrence of diolepoxide-derived adducts in mouse lung after 1,3-butadiene exposure.
Koivisto P; Kilpeläinen I; Rasanen I; Adler ID; Pacchierotti F; Peltonen K
Carcinogenesis; 1999 Jul; 20(7):1253-9. PubMed ID: 10383898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
